Study name |
Comparison of the effect of two progesteron drugs in protection of abortion |
Methods |
2‐arm active‐controlled randomised trial. |
Participants |
Pregnant women with gestational age between 6 and 13 weeks, presence of a fetal heart beat, uterine bleeding and a closed uterine orifice. Exclusion criteria include embryonic or uterine anomalies identified by ultrasound, multi‐fetal hydatidiform mole, known underlying disease in mother, women who have been treated by a specific medication to treat abortion. |
Interventions |
400 mg daily vaginal progesterone versus 100 mg daily oral progesterone |
Outcomes |
Abortion, pre‐eclampsia, gestational diabetes |
Starting date |
21‐Apr‐2018 |
Contact information |
hpakniat@qums.ac.ir |
Notes |
|